Sulmasy D P, Terry P B, Weisman C S, Miller D J, Stallings R Y, Vettese M A, Haller K B
Georgetown University Medical Center, Washington, DC 20007, USA.
Ann Intern Med. 1998 Apr 15;128(8):621-9. doi: 10.7326/0003-4819-128-8-199804150-00002.
Patients' loved ones often make end-of-life treatment decisions, but the accuracy of their substituted judgments and the factors associated with accuracy are poorly understood.
To assess the accuracy of judgments made by surrogate decision makers; ascertain the beliefs, practices, and clinical and sociodemographic factors associated with accuracy of surrogates' decisions; assess the preferences of patients for life-sustaining treatments; and compare differences in accuracy across diagnoses.
Cross-sectional paired interviews.
Outpatient practices of three university hospitals.
250 patients with terminal diagnoses of congestive heart failure, AIDS, amyotrophic lateral sclerosis, lung cancer, and chronic obstructive pulmonary disease (50 patient-surrogate pairs in each group) and 50 general medical patients and their surrogates.
The accuracy of surrogate predictions was measured by using scales based on 10 potential treatments in each of three hypothetical clinical scenarios.
Preferences varied according to mode of treatment and scenario. On average, surrogates made correct predictions in 66% of instances. Accuracy was better for the permanent coma scenario than for the scenarios of severe dementia or coma with a small chance of recovery (P < 0.001). In a binary logit model, the accuracy of substituted judgments was positively associated with the patient having spoken with the surrogate about end-of-life issues (odds ratio [OR], 1.9 [95% CI, 1.6 to 2.3]), the patient having private insurance (OR, 1.4 [CI, 1.1 to 1.7]), the surrogate's level of education (OR, 1.5 [CI, 1.2 to 1.9]), and the patient's level of education (OR, 1.7 [CI, 1.4 to 2.2]). Accuracy was negatively associated with the patient's belief that he or she would live longer than 10 years (OR, 0.6 [CI, 0.5 to 0.7]), surrogate experience with life-sustaining treatment (OR, 0.4 [CI, 0.3 to 0.5]), surrogate participation in religious services (OR, 0.67 [CI, 0.50 to 0.91]), and a diagnosis of heart failure (OR, 0.6 [CI, 0.5 to 0.8]). Age, ethnicity, marital status, religion, and advance directives were not associated with accuracy.
The accuracy of substituted judgments is associated with multiple clinically apparent patient and surrogate factors. This information can help clinicians identify conditions under which substituted judgments are likely to be accurate or inaccurate and can help target populations for education designed to improve the accuracy of surrogate decision making.
患者的亲人常常会做出临终治疗决策,但对于他们替代判断的准确性以及与之相关的因素,我们了解甚少。
评估替代决策者所做判断的准确性;确定与替代者决策准确性相关的信念、做法、临床及社会人口学因素;评估患者对维持生命治疗的偏好;并比较不同诊断情况下准确性的差异。
横断面配对访谈。
三家大学医院的门诊。
250例终末期充血性心力衰竭、艾滋病、肌萎缩侧索硬化症、肺癌和慢性阻塞性肺疾病患者(每组50对患者 - 替代者)以及50例普通内科患者及其替代者。
通过使用基于三种假设临床场景中每种场景下10种潜在治疗方法的量表来测量替代者预测的准确性。
偏好因治疗方式和场景而异。平均而言,替代者在66%的情况下做出了正确预测。永久性昏迷场景下的准确性优于严重痴呆或恢复机会较小的昏迷场景(P < 0.001)。在二元逻辑回归模型中,替代判断的准确性与患者是否与替代者谈论过临终问题呈正相关(优势比[OR],1.9 [95%置信区间,1.6至2.3]),患者是否拥有私人保险(OR,1.4 [置信区间,1.1至1.7]),替代者的教育程度(OR,1.5 [置信区间,1.2至1.9])以及患者的教育程度(OR,1.7 [置信区间,1.4至2.2])。准确性与患者认为自己能活超过10年的信念呈负相关(OR,0.6 [置信区间,0.5至0.7]),替代者对维持生命治疗的经验(OR,0.4 [置信区间,0.3至0.5]),替代者参加宗教活动的情况(OR,0.67 [置信区间,0.50至0.91])以及心力衰竭诊断(OR,0.6 [置信区间,0.5至0.8])。年龄、种族、婚姻状况、宗教信仰和预先指示与准确性无关。
替代判断的准确性与多种临床上明显的患者和替代者因素相关。这些信息可帮助临床医生识别替代判断可能准确或不准确的情况,并有助于针对旨在提高替代决策准确性的教育目标人群。